RELX Issues Unaudited Financial Report for Q2

Market by Ashe Wong
Aug.18.2023
RELX Issues Unaudited Financial Report for Q2
RLX Technology Inc. reported unaudited Q2 2023 financial results, showing a 100.2% QoQ increase in net revenue.

On August 18th, RLX Technology Inc. released its unaudited financial report for the second quarter of 2023. According to the report, the company achieved a net revenue of RMB 380 million (USD 52.15 million) during the second quarter of 2023, representing a 100.2% increase compared to the previous quarter but an 83.1% decrease year-on-year. Adjusted net profit for the second quarter, excluding U.S. GAAP, amounted to RMB 86.23 million (USD 11.89 million).

 

According to the financial report, Wuxin Technology's net revenue in the second quarter of 2023 reached 380 million Yuan ($52.15 million), showing a 100.2% increase compared to the previous quarter but a decline of 83.1% compared to the same period last year.

 

The gross profit margin for the second quarter of 2023 stood at 26.1%.

 

According to non-US generally accepted accounting principles, the adjusted net profit for the second quarter of 2023 was 86.23 million yuan (11.89 million US dollars).

 

As of June 30, 2023, Wuxin Technology's total cash and cash equivalents, restricted cash, short-term bank deposits, short-term investments, long-term bank deposits, and long-term investment securities amounted to RMB 15.79 billion ($2.18 billion).

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14